Delta variant infects extremely vaccinated jail inhabitants, however few hospitalized

A sheriff’s deputy measures on Wednesday, April 22.

Sandy Huffaker | AFP | Getty Images

The rapidly spreading Delta variant broke through a federal prison in Texas in the summer and infected both the unvaccinated and fully vaccinated populations, but few were hospitalized, according to a report released Tuesday by the Centers for Disease Control and Prevention.

Of the 233 detainees in the prison that was not named, 185 or 79% were fully vaccinated Covid19according to the new report published in the agency’s Morbidity and Mortality Weekly Report.

From July to August, 172 inmates or 74% of the federal prison population were infected with Covid, according to the CDC. The Delta variant hit the unvaccinated harder, the agency said, and infected 39 of the 42 prisoners who were not given the syringes. That compares to the 129 infections from 185 fully vaccinated people.

According to the CDC, four people were hospitalized, three of whom were unvaccinated, and one person who was unvaccinated died.

The agency said the report shows the potential for Delta variant outbreaks in community facilities, including correctional facilities and detention centers, even in locations and populations with high vaccination rates.

“Although attack rates, hospital admissions and deaths were higher in unvaccinated people than vaccinated people, the duration of positive serial test results was similar for both groups,” the agency wrote in the report.

Vaccinating the majority of the US population remains vital as vaccinations are highly effective in preventing serious illness, hospitalizations and deaths, the agency said.

The new report comes as federal health officials urge all Americans to get vaccinated and continue to wear masks indoors, especially in meeting places, as the highly contagious Delta variant spreads across the country.

The US still has a dangerously high number of cases. The nation reports an average of more than 138,900 cases a day on Tuesday, according to data from Johns Hopkins University. The country reports an average of more than 1,900 deaths a day, data from Johns Hopkins shows.

Earlier this month, President Joe Biden outlined a broad plan to increase Covid vaccination rates in the US, pressures on private employers to immunize their workforce; and order vaccinations for federal employees, contractors and healthcare workers.

The plan is to offer boosters of Pfizer and Moderna vaccines to the general population.

An advisory committee to the Food and Drug Administration on Friday recommended unanimously Pfizer Booster Vaccinations For People 65+ And Other At-Risk Americans. A final decision from the agency is now expected every day.

CDC scientist says knowledge is proscribed to judge shot for normal inhabitants

A CDC scientist said Monday that the data needed to properly evaluate Covid-19 vaccine booster vaccinations for the general population is limited – even if President Joe Biden pressures health officials to delete the vaccinations widespread use early in the week from September 20th.

The presentation by Dr. Sara Oliver at a meeting of the Centers for Disease Control and Prevention Advisory Group suggests the panel may limit its initial endorsement of additional shots to vulnerable groups and healthcare workers.

A nurse vaccinates 15-year-old Sherri Trimble at a vaccination clinic at Health First Medical Center in Melbourne, Florida.

Paul Hennessy | SOPA pictures | LightRakete | Getty Images

Several studies suggest that the approved Covid vaccines may still be effective in preventing serious illness and hospitalization, but may be less effective in preventing infections or mild symptomatic illnesses, according to Oliver. The CDCs The Advisory Committee on Vaccination Practices meets on Monday Consider booster vaccinations for all eligible Americans. The panel is also due to vote on the final approval of the Pfizer vaccine by the Food and Drug Administration.

Since the highly contagious Delta variant first appeared, the vaccine’s effectiveness ranged from 39% to 84%, according to Oliver’s presentation, which referred to several separate studies. A study that looked at health care workers and first responders showed that the vaccine’s overall effectiveness dropped to about 65% in July – up from about 90% in February. Israel dates show Pfizer’s vaccine effectiveness has dropped to just 39% in that country.

Scientists have said that the vaccines become less effective over time, and the Delta variant is a more resilient strain that is able to break through that protection.

According to Oliver’s presentation slides, “it is important to monitor efficacy trends by disease severity over time”.

It was pointed out on the slides that vaccines often require multiple doses. Hepatitis B and HPV vaccinations, for example, require a third dose after six months.

“Vaccines that require more than one dose don’t necessarily mean that an annual booster is required,” Oliver said during the presentation.

Once booster shots are available, nursing home residents, health care providers, and the elderly – the first groups to be vaccinated in December and January – will likely be given priority for the additional vaccinations, according to the CDC slides.

The CDC stressed that vaccinating the unvaccinated should be a “top priority” and giving booster doses to vaccinated individuals should not deter those who remain unprotected from the virus.

The agency also emphasized the importance of vaccine availability around the world.

“An uncontrolled global spread that could lead to new variants threatens the control of the pandemic everywhere,” said Oliver. In addition to global distribution, policy on boosters “should also consider equity in the US population,” she added.

Monday’s meeting comes after President Joe Biden said Friday US regulators are considering giving Covid booster vaccinations five months after completing the primary series and bringing forward the expected schedule for a third vaccination by three months.

Scientists have sharply criticized The Biden government’s urge to distribute booster syringes widely says the data provided by federal health officials are not compelling enough to currently recommend third vaccinations for most of the American population.

The Biden government has publicly stated that the third dose will not be given without FDA approval and a vote from ACIP.

There can be sufficient Covid vaccines for the ‘whole U.S. grownup inhabitants by June,’ physician says

Johnson & Johnson Board member Dr. Mark McClellan told CNBC Friday that there could be enough vaccinations for the entire US adult population by the summer.

“Assuming that the exact verification of the J&J data is no longer possible, we have the capacity between Modern, Pfizer, J&J to have enough vaccines available for the entire US adult population by June, “McClellan, a former FDA commissioner, said on “The news with Shepard Smith. ”

The US plans to buy 200 million doses of Covid vaccine from Modern and Pfizer. The Department of Health and Human Services will increase its vaccine supply to states from 8.6 million to at least 10 million doses per week. To date, states have received more than 49 million doses, but only about half of that actually ended up in people’s arms Centers for Disease Control and Prevention. The agency reports that the US fires just over a million shots every day.

McClellan that the US should significantly increase the number of shots given per day and “should bring our ability to vaccinate closer to 3 million doses per day.”

The US has ordered 100 million doses of the J&J vaccine, which the company plans to deliver by June. J&J plans to apply for an emergency permit next week. If J & J’s vaccine is FDA approved, it would be the third emergency approved vaccine in the US Pfizer vaccine approved by the FDA on December 11 and Moderna’s has been authorized one week later.

The effectiveness of the J&J vaccine numbers were lower than those for Pfizer and Moderna. Pfizer’s vaccine was found to be 95% effective against Covid-19, while Moderna’s vaccine was about 94% effective. J & J’s vaccine was found to be 66% overall effective in preventing moderate to severe Covid.

Host Shepard Smith asked McClellan about the lower efficacy numbers compared to Pfizer and Moderna, explaining to Smith, “We are fighting a different virus today than three months ago when previous studies were done.”

In addition, J&J conducted its process on three continents and the level Protection varies by region. The vaccine showed an overall effectiveness of 72% in the US and 66% in Latin America. In South Africa, where it’s dangerous B.1.351 strain of Covid caused an increase in some cases, the J&J vaccine showed 57% effectiveness.

“Unfortunately, in three months’ time, we’ll likely be fighting another virus. The most important thing to winning this fight is getting as many people as possible vaccinated,” said McClellan. “The faster we shoot in the arms, the more people will be vaccinated here in this country and around the world, the better we can contain this further spread and further damage from Covid.”